Gujarat Alkalies Plans ₹293 Crore Borrowing for FY26

Gujarat Alkalies and Chemicals Limited (GACL) has outlined its borrowing plans for the fiscal year 2025-26, disclosing an intention to raise Rs 292.63 crore. This filing, made on May 8, 2026, follows recent SEBI circulars aimed at simplifying business operations and boosting the corporate bond market.

GACL Discloses FY26 Borrowing Plan

Gujarat Alkalies and Chemicals Limited (GACL) has submitted its annual borrowing disclosure, planning to raise Rs 292.63 crore for the financial year 2025-26. This move aligns with SEBI's efforts to ease business operations and support the corporate bond market. The disclosure offers investors insight into GACL's forward-looking funding strategy and how it plans to manage its financial leverage in the capital-intensive chemical sector.

GACL's Business Context

GACL is a key player in India's chemical industry, producing caustic soda, chlorine, and hydrogen. The company operates advanced manufacturing facilities in Gujarat, catering to a wide range of industrial clients. GACL has been pursuing expansion, including increasing caustic soda capacity and developing products like methanol. These growth projects require substantial investment, making debt financing critical for its development. SEBI's initiatives aim to simplify corporate funding access and deepen the debt market.

Investor Implications

The disclosure signals GACL's intention to use debt markets for its FY26 funding needs. Investors should expect a potential increase in the company's debt levels. This plan demonstrates GACL's compliance with SEBI's regulatory framework for large corporations and offers stakeholders a clearer view of its financial planning.

Comparison with Peers

Other chemical companies, such as Tata Chemicals and DCM Shriram, also manage significant capital demands for growth and operations, balancing expansion with debt management.

Key Financial Metrics (FY23)

• Total consolidated debt: Rs 2,152.0 crore
• Consolidated debt-to-equity ratio: 0.74
• Consolidated sales growth: 3.6% (FY23 vs FY22)
• Consolidated interest coverage ratio: 3.97

Investor Watchlist

Investors will monitor:

• The actual debt GACL raises and its terms in FY26.
• The impact on its debt-to-equity and interest coverage ratios.
• How the borrowed funds are used (e.g., for capital projects or working capital).
• Management's discussions on debt strategy.
• Overall trends in the Indian chemical sector.